ANPUD Consultants Roster 2018: Call for Applications

The purpose of this call for consultants is to develop a roster of consultants (experts) for the year 2018. It will primarily benefit ANPUD by reducing the time and level of effort that is required while hiring a consultant. With the launch of ANPUD’s new strategic plan 2018-2022, it is essentially important for ANPUD to become efficient and deliver its action plans on time.

Global Coalition Calls for International Criminal Court Intervention in the Philippines

As Philippine Government sponsored mass killings top 13,000, a global coalition of NGOs and advocates say International Criminal Court (ICC) intervention is urgent following the Philippine governments denials and threats to withdraw from the ICC.

Apple Removes Games promoting Duterte’s War on Drugs

ANPUD led a global petition demanding Apple Incorporation’s Chief Executive Officer (CEO) Mr. Tim Cook to urgently perform a formal review and remove all the apps made available by Apple immediately and issue an apology for hosting insensitive content. The petition was a successful advocacy effort in that the letter was able to generate huge media attention and some of the games were removed from the App Store. The case study is intended to document the story of victory and disseminate the detailed set of actions performed in the process.

An Open Letter to Apple CEO Mr. Tim Cook: Immediately remove apps that are promoting war on drugs in the Philippines.

In the letter, 131 organizations including human rights and drug policy reform groups have demanded Apple to immediately remove apps (games) that are promoting murder, extrajudicial killings, violence, and the war on drugs in the Philippines.

World Drug Report 2017

The 2017 report comes at a time when the international community has acted decisively to achieve consensus on a way forward for joint action.

Appeal to the Pope: “excommunicate Duterte!”

Over 300 people from church, politic, culture, drugs Help- and human rights structures from Germany, Switzerland, Austria, Netherlands, Belgium, France, UK, Italy, Spain, Czech Republic, Norway, Slovenia, Canada, Australia, South Africa , El Salvador, Argentina, Mexico, Hong Kong and the USA have appealed to the Pope in Rome.

GLOBAL WEEK OF ACTION 2016

The Asian Network of People who Use Drugs (ANPUD) and the International Network of People who Use Drugs (INPUD), through our national network allies and colleagues, are leading a global week of action against the extrajudicial killings of people who use drugs in the Philippines. The global week of action will take place in the week beginning October 10th 2016. The week will focus actions at embassies and consulates of the Philippines around the world. You are encouraged to take the lead in identifying an appropriate date in the week for a peaceful demonstration at embassies and consulates.

PHILIPPINES: An Entreaty to End the Killing, to End the Poverty and Exclusion

INPUD (the International Network of People who Use Drugs) and ANPUD (the Asian Network of People who Use Drugs) urgently request a halt be called on the killing of people who use drugs in the Philippines. We implore Your Excellency President Duterte to reconsider the current approach of executing people who use drugs in favour of internationally accepted, evidence-based alternatives.

6th Plenary at UNGASS: Mr. Charan Sharma (Secretary of IDUF, India) speaking for the community

Mr. Charanjit Sharma, from Manipur in North-East India, is the secretary of the Indian Drug Users Forum (IDUF). He is also involved with the India HIV/AIDS Alliance.
Being recently selected as a Civil Society Speaker out of 257 applicants, he, with his grassroot experiences, represented drug user community and addressed our issues at the United Nations General Assembly Special Session (UNGASS) on the World Drug Problem held during 19-21 April 2016 at the United Nations Headquarters in New York. He spoke in the 6th plenary along with 4 other Civil Society speakers from different parts of the world.
The verbatim script of his speech and video is published. Please go to time 2:28:50 to directly watch Mr. Charan’s speech.

DDW 2015: Sofosbuvir + Daclatasvir for 12 Weeks Cures Most HIV/HCV Coinfected Patients

Kenneth Sherman from the University of Cincinnati presented findings from the Phase 3 ALLY-2 trial, which evaluated Gilead Sciences’ nucleotide polymerase inhibitor sofosbuvir plus Bristol-Myers Squibb’s NS5A inhibitor daclatasvir without ribavirin.
Daclatasvir is available in Europe and Japan and is currently awaiting U.S. Food and Drug Administration approval. Gilead’s Harvoni coformulation contains sofosbuvir plus its own NS5A inhibitor, ledipasvir. Unlike ledipasvir, which is active against genotype 1, daclatasvir is more pangenotypic, meaning it works against multiple HCV genotypes.